Argent Biopharma (AU:RGT) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Argent Biopharma Limited has announced the cessation of several securities due to the expiry of options and conditional rights. Specifically, 12,100 Performance Rights, 5,400 Class C Performance Rights, and 250 Class E Performance Rights have lapsed as conditions were not met or the options were not exercised. This change in the company’s issued capital could be of significant interest to investors monitoring Argent Biopharma’s financial movements.
For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.